Clinical Trial Update: Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia [Phase 4]

View source ↗

Summary

This entry reports the completed Phase 4 trial evaluating clinical outcomes of inhaled amikacin in patients with ventilator-associated pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Inhaled amikacin (amikacin)

Snippet

Sponsor: Postgraduate Medical Institute, Lahore | Conditions: Ventilator Associated Pneumonia ( VAP) | Phase 4 | Status: COMPLETED